Daiichi Sankyo and the National Cancer Center form comprehensive research alliance
22 May 2012
This agreement is designed to integrate the high-level cancer research technology...
Industry news
FDA approves new labeling for ISENTRESS® (raltegravir)
21 May 2012
The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study...
Capital increase in Lundbeck as a result of employee warrant programme
21 May 2012
Lundbeck increases its share capital by 593 shares as a result of employee warrant exercise...
Two overall winners announced at prestigious national award ceremony in London’s Science Museum
18 May 2012
Judges of the GSK IMPACT Awards could not choose one overall winner for the awards...
New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine
18 May 2012
Use of biomarker has potential to advance personalised treatment for MS patients...
NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN)
18 May 2012
Janssen Pharmaceuticals announce results of an investigational Phase 3 study...
Pfizer exploratory study measures effects of Lyrica (pregabalin) on brain activity in fibromyalgia patients
18 May 2012
Results of studies on Lyrica® announced...
GSK statement on tender offer to acquire Human Genome Sciences
18 May 2012
GSK believes its offer represents full and fair value and is in the best interests of both companies’ shareholders...
ArQule and Daiichi Sankyo announce completion of patient recruitment in Phase 3 clinical trial of Tivantinib in non-small cell lung cancer
18 May 2012
ArQule and Daiichi Sankyo announced that recruitment of patients has been completed...
Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients
17 May 2012
Results from pivotal Phase III GLOW2 study...
Teva’s Board of Directors votes to re-elect Dr. Phillip Frost as Chairman of the Board
17 May 2012
“Dr. Phillip Frost has the Board’s full support..."
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content